FDA OrangeBook code

U-4146

FIRST-LINE TREATMENT OF PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) USING DOSAGE MODIFICATIONS FOR ADVERSE REACTIONS